Offering Summary

Maximum 2,229,166 shares* of "B" Non-voting Common Stock ($1,069,999.68) *Maximum subject to adjustment for bonus shares. See 10% Bonus below Minimum 20,833 shares of "B" Non-voting Common Stock ($9,999.84)

Company

HEAL Diabetes Clinics Inc





Corporate Address

15332 Antioch Street, #438, Pacific Palisades, CA 90272





Description of Business

Medical diabetes and pre-diabetes management, non-medical weight loss





Type of Security Offered

"B" Non-voting Common Stock



Purchase Price of Security Offered

$0.48





Minimum Investment Amount (per investor)

$480



















PERKS* $ 1,000 – HEALcare gift certificate for $50

A $50 gift certificate for HEAL care services.

A $50 gift certificate for HEAL services. $2,500 – Phone consultation with Dr. Eric Westman

Previous perk plus a private one-hour phone consultation with Dr. Eric Westman.

Previous perk plus a private one-hour phone consultation with Dr. Eric Westman. $5,000 – HEAL care gift certificate for $500

Previous perks plus a $500 gift certificate for HEAL care services.

Previous perks plus a $500 gift certificate for HEAL services. $20,000 – Private dining with Dr. Eric Westman at LowCarbUSA 2019 in San Diego

All previous perks plus a paid registration pass to LowCarbUSA 2019 in San Diego and an invitation to a private gourmet keto dinner during the conference with Dr. Eric Westman and other $20,000+ investors. Does not include travel or accommodations

All previous perks plus a paid registration pass to LowCarbUSA 2019 in San Diego and an invitation to a private gourmet keto dinner during the conference with Dr. Eric Westman and other $20,000+ investors. Does not include travel or accommodations Early Bird Discount

Investors who invest on or before November 11th, 2018 (11:59pm PT) will receive a 6% early bird discount on the price per share ($0.45).



*Investors receive these perks when their investments meet or exceed the amounts shown.

*Perks are transferable to relatives or friends but cannot be sold. Perks are provided after the offering is complete.

10% Bonus for StartEngine Shareholders StartEngine shareholders who have invested $1,000+ in the StartEngine Reg A+ campaign will receive a 10% bonus on this offering within a 24-hour window of this campaign's launch date. This means you will receive a bonus for any shares you purchase. For example, if you buy 1,000 shares of Common "B" Non-voting Stock at $0.48 / share, you will receive 100 bonus shares, meaning you'll own 1,100 shares for $480. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share. This 10% Bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors receive their countersigned StartEngine Crowdfunding Inc. subscription agreement.



Irregular Use of Proceeds

Example - The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.

Most recent fiscal year-end: Prior fiscal year-end: Total Assets $63,308.00 USD $37,960.00 USD Cash And Cash Equivalents $51,875.00 USD $30,900.00 USD Accounts Receivable $0.00 USD $0.00 USD Short Term Debt $0.00 USD $0.00 USD Long Term Debt $0.00 USD $0.00 USD Revenues And Sales $99,596.00 USD $24,046.00 USD Costs Of Goods Sold $48,451.00 USD $28,696.00 USD Taxes Paid $0.00 USD $0.00 USD Net Income -$726,609.00 USD -$714,900.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.